|
Characteristics of patients and healthy controls. |
|||||
| Group Subject n. |
Sex |
Age range (median) |
Patch test to Ni |
Patch test to Pd |
Patch test to Rh |
|
|
|||||
| 1 n = 10 |
9 F |
28 – 40 (30) |
9 +++ |
9 - |
9 - |
| 1 M |
30 |
1 +++ |
1 - |
1 - |
|
| 2 n = 10 |
9 F |
28 – 38 (33) |
9 - |
7+++/2 ++ |
9 - |
| 1 M |
40 |
1 - |
1 ++ |
1 - |
|
| 3 n = 10 |
9 F |
29 – 40 (32) |
9 +++ |
6 ++/3 + |
9 - |
| 1 M |
39 |
1+++ |
1 + |
1 - |
|
| 4 n = 10 |
9 F |
28 – 38 (33) |
9 - |
9 - |
9 - |
| 1 M |
36 |
1 - |
1 - |
1 - |
|
|
As described in the methods, patch test reactivity to the different metal salts was defined as strong (+++: oedema, erythema, papules and vesicles), moderate (++: oedema, erythema and papules), weak (+: oedema and erythema) or no reaction (-). | |||||
Bordignon et al. BMC Immunology 2008 9:19 doi:10.1186/1471-2172-9-19 |
|||||